T1	Outcomes 543 561	2-h glucose levels
T2	Outcomes 606 640	rates of target 2-h glucose levels
T3	Outcomes 784 804	of 2-h glucose level
T4	Outcomes 821 874	of homeostasis model assessment of insulin resistance
T5	Outcomes 939 979	the target fasting and 2-h glucose level
T6	Outcomes 1088 1111	on repaglinide efficacy
